After 13 Years, China's First Original Three-Generation ABL Inhibitor Oribatinib Was Approved for Marketing
With the coming Oil & Gas Asia Exhibition in Pakistan, ECHEMI rolls out a new bulk purchasing activity for its new and old customers. This activity will be valid before March 16 when the exhibition come to the end. The more you buy, the more money you will save.
How to join this bulk purchasing?
You can enjoy the most favorable prices via three steps:
First, you should come to the home page of ECHEMI, then you can see the the following page:
Second, input your demand and submit the inquiry.
Third, ECHEMI will give you a reply within 1 working day after receiving your inquiry.
Opportunity knocks but once! Come on, seize this opportunity right now!
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-07-13
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
JAK inhibitor, the successor to Hummero?
-
AstraZeneca/Mersk & Co.'s MEK Inhibitor Filed for Listing in China
-
Roche's Next-generation C5 Complement Inhibitor Crovalimab Successfully Completed Phase III Study in China
-
The World's First PI3Kδ/CK1ε Inhibitor Was Frustrated
-
FDA approves the first topical JAK inhibitor to treat atopic dermatitis
-
Merck to Lay Off 150 Workers at US Gardasil Plant Amid Sales Weakness
-
Glenmark’s $1 Billion Cancer Bet: Oncology Revolution Set to Ignite in FY28
-
NHU and Sinopec Advance Liquid Methionine Project
-
Lilly’s U.S. API Investment Highlights a New Phase of Pharma Supply Localization
-
Roche Keeps German Diagnostics Investment
Recommend Reading
-
Platinum Chemotherapy Shortages Expose the Fragility of Essential API Supply
-
India Raises Cancer Drug Price Caps by 50%
-
Pfizer Warns Germany Over Drug-Pricing Policy
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
-
U.S. Health Chief Says No Evidence Linking Tylenol to Autism
-
Premium Global Chemical Sourcing Requests (23-26Apr, 2026)
-
HARKE GROUP Acquires Vendico Group, Strengthening Nordic Market leadership
-
ECHEMI High Quality Inquiries (21-25 Jul)
-
Kemira to Expand Drinking Water Treatment Portfolio with New ACH Production Line
-
Supply and Demand Easing Coupled with Bearish Moving Averages, Melamine Spot Prices Continue to Weaken in China